Although apolipoprotein E (ApoE) ε4 is a well-established risk factor for Alzheimer disease, its role in the development of post-stroke cognitive impairment (PSCI) remains uncertain. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.